Gerresheimer buys majority stake in Triveni
Triveni manufactures and produces plastic containers and closures for the pharma industry, for which it has received the American FDA’s approval. Gerresheimer CFO Hans-Jurgen Wiecha said the purchase
WellSpan Health and Johns Hopkins Medicine have renewed their oncology collaboration, aiming to widen patient access to advanced care, clinical expertise, and research initiatives throughout central Pennsylvania, US.
The products include Chemet (succimer), Cosmegen (dactinomycin for injection), Desoxyn (methamphetamine hydrochloride), Elspar (asparaginase), Indocin (indomethacin), Mustargen (mechlorethamine HCL for injection), NeoProfen (ibuprofen lysine), Panhematin (hemin), Peganone (ethotoin)